Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG NFLX AMZN BIIB IBB TSLA ALXN WYNN AMGN GMCR COST SIAL AAPL Z VRTX MNST CELG SLXP WDC
Nyse: ACT V LNKD AGN IVV GS LMT SPG PXD FDX IBM MMM CMI APD GD TWC NOC HUM BA PH
New Highs: BLK AMGN APD GD NOC AMP FFIV TMO RCPT UNP SBAC PANW VNO CELG RTN AMT HON AON WAB ROST

The Hot Industries

Biotechnology 3
Asset Management 2
Railroads 2

The Hot Sectors

Financial 5
Healthcare 4
Services 4

AMRN Stock Chart


AMRN
Analyze

Sector:

Healthcare
Daily

Industry:

Drug Manufacturers - Other
Weekly

Employees:

185
Monthly

Website:

http://www.amarincorp.com

AMRN Amarin Corporation plc

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

favicon

Amarin Corporation plc (AMRN) in Focus: Stock Soars 23.4% - Tale of the Tape

19 Nov 2014, 8:58 amAmarin Corporation plc (AMRN) in Focus: Stock Soars 23.4% - Tale of the Tape
favicon

Amarin Corporation plc (AMRN) in Focus: Stock Soars 23.4%

19 Nov 2014, 4:12 amAmarin Corporation plc (AMRN) was a big mover last session, as the company saw its shares rise by over 23% on the day.
favicon

Amarin up again today on Vascepa data

18 Nov 2014, 9:47 amAmarin ( AMRN +22.4% ) is up again today on a 50% increase in volume as money flows into the stock in response to a presentation of new data and analyses from the Marine and Anchor Phase 3 Vascepa (icosapent ethyl) trials. Shares are now up 54% from the low of $0.78 on November 11.
favicon

Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind

14 Nov 2014, 4:47 pmBiotech columnist Adam Feuerstein answers readers' questions about health care. Click to view a price quote on ICPT . Click to research the Drugs industry.
favicon

Amarin Reports Third Quarter 2014 Financial Results and Provides Update on Operations

6 Nov 2014, 2:00 pmAmarin Corporation plc  , a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for the three ...
favicon

MTNB: Initiating Coverage On Matinas BioPharma - A New Player In The Fish Oil Market

30 Oct 2014, 8:00 amMatinas is developing MAT9001, a proprietary prescription grade omega-3 fatty acid composition, comprised of a complex mixture of omega-3 fatty acids, predominantly eicosapentaenoic acid (“EPA”), and docosapentaenoic acid (“DPA”), a rare and potent omega-3 fatty acid. The product also contains several other omega-3 fatty acids, including relatively small amounts of docosahexaenoic acid (“DHA ...